Saturday, April 3, 2021

Vitamin D3 And Cancer

Vitamin D3 And Cancer

Studies report people who have high levels of vitamin D3 have a lower risk of developing certain cancers. One study suggests that taking calcium and vitamin D supplements together can reduce the risk of colon cancer, and another study that looked at postmenopausal women taking calcium vitamin D supplements found that they had no lower risk of colon cancer than those who did not. 

Moreover, researchers do not know how much vitamin D one needs to take to get all these benefits. Since vitamin D is necessary for bone health, make sure your food contains enough of it to provide it to you.    

In laboratory studies, vitamin D has shown the ability to induce programmed cell death, inhibit the growth of cancer cells, and reduce the metastatic potential. A prospective observational study linked higher levels of vitamin D in the blood to a reduction in the risk of breast and prostate cancer and a reduction in breast cancer mortality, but the study could not prove that vitamin D was the cause. A randomized, double-blind phase 3 trial enrolled patients to test whether vitamin D supplementation can improve outcomes in patients with metastatic colorectal cancer.     

For example, people with higher levels of vitamin C in their blood have been found to have a lower risk of certain cancers, including colorectal and breast cancer. A new clinical study has found that higher doses of vitamin D supplements may not lower the risk of older women developing cancer, but they can lower the risk in younger women.   

In laboratory tests, vitamin D has also shown activity that can slow the growth of cancer, such as promoting the death of abnormal cells. In a secondary analysis for VITAL, the research team has now focused on the effects of taking a vitamin D supplement on a number of cancers, from colorectal and breast cancer to prostate cancer. The study, which is due to be completed in 2018, found that vitamin D did not reduce the overall incidence of these cancers, but indicated a reduced risk of cancer and death.   

A report published in the Journal of the American Academy of Cancer Research (JACR) Last year, vitamin D was found to be linked to a reduced risk of breast, colon and prostate cancer.   

The team found a 38% risk reduction when they looked at the risk of breast, prostate and prostate cancer in men and women of the same age, suggesting body mass could influence the reduced risk. They also concluded that taking a daily dose of 1,000 mg of vitamin D3 could potentially reduce the risk of colorectal cancer by up to 50%.   

Other studies have shown that improving vitamin D status has the potential to reduce colorectal cancer by about 25-50%, depending on the study. So there is evidence that improving vitamin D status can help reduce breast cancer risk, and there is evidence that it can reduce the risk of other types of tumors.   

There is evidence that adequate vitamin D intake can reduce the risk of certain cancers such as colorectal, breast and prostate cancer.   

This evidence is largely based on studies from large population studies and does not prove that taking vitamin D reduces the risk of certain cancers, such as colorectal, breast, and prostate. Population - Based studies and laboratory studies also suggest that higher vitamin D levels are associated with a lower risk of skin cancer. Although there is no evidence that the higher the vitamin D level in the body, the greater the risk of deficiency, the more the breadth and breed of vitamin D status differ.    

Although research has determined the possible association of vitamin D with cancer, these studies have produced mixed results. A PubMed database search reveals a large number of studies on the association between vitamin D3 and cancer risk, including several that assess the association between vitamin C levels in the body and cancer risk. The majority of studies did not show any association with a lower risk of breast, colon, prostate and prostate cancer and no association with vitamin D2 levels.   

Some epidemiological studies have shown that vitamin D can be associated with a lower risk of breast, colon, prostate and prostate cancer, but not cancer-related mortality. Some studies on the association between vitamin D3 and cancer risk in men and women have shown that it can reduce cancer risk and mortality, and some have shown that vitamin D3 does not reduce the occurrence of some cancers.   

More recently, a secondary analysis of VITAL published in JAMA Network Open showed a reduced risk of pancreatic cancer in men and a lower risk in women. A large study has found that an increase in 25 hydroxyvitamin D3 levels is associated with a reduced risk of certain cance3. This study provides strong human data to support the hypothesis that low vitamin D levels increase susceptibility to pancreatic cancer when coupled with other known risk factors such as high blood pressure and obesity. The study was conducted at the University of California, San Diego School of Medicine and the National Cancer Institute.